Skip to main content
David Jarrard, MD, Urology, Madison, WI, University Hospital

DavidFJarrardMD

Urology Madison, WI

Minimally Invasive Surgery, Surgical Oncology

Vice Chair and Professor of Urology John Livesey Chair in Urologic Oncology Associate Director, UW Carbone Cancer Center

Dr. Jarrard is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Jarrard's full profile

Already have an account?

Education & Training

  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineFellowship, Minimally Invasive Urologic Surgery, 1994 - 1996
  • University of Chicago Medical Center
    University of Chicago Medical CenterResidency, Urology, 1990 - 1994
  • University of Chicago
    University of ChicagoInternship, Transitional Year, 1989 - 1990
  • University of Virginia School of Medicine
    University of Virginia School of MedicineClass of 1989

Certifications & Licensure

  • WI State Medical License
    WI State Medical License 1996 - 2023
  • MD State Medical License
    MD State Medical License 1994 - 1996
  • IL State Medical License
    IL State Medical License 1989 - 2023
  • American Board of Urology Urology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly
  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • The Impact of Statins in Combination with Androgen Deprivation Therapyin Patients with Advanced Prostate Cancer: A Large Observational Study  
    Natasza Posielski, Tariq A Khemees, David F Jarrard, Kyle A Richards, Urologic Oncology

Authored Content

  • SUO 2020: Drug Intervention for Active Surveillance with ApalutamideDecember 2020
  • The Impact of Statins in Combination with Androgen Deprivation Therapyin Patients with Advanced Prostate Cancer: A Large Observational StudyDecember 2018

Press Mentions

  • Study Provides Cellular Explanation for Higher Risk of Prostate Cancer in Aging Men
    Study Provides Cellular Explanation for Higher Risk of Prostate Cancer in Aging MenAugust 24th, 2017
  • Metformin May Improve Advanced Prostate Ca Outcomes
    Metformin May Improve Advanced Prostate Ca OutcomesAugust 1st, 2017
  • Researchers Awarded $3 Million to Study Therapy Resistance in Prostate Cancer
    Researchers Awarded $3 Million to Study Therapy Resistance in Prostate CancerMay 12th, 2016
  • Join now to see all

Grant Support

  • Modulation Of IGF-II Imprinting In The Aging ProstateNational Cancer Institute2002–2012
  • Modulation Of IGF-II Imprinting In The Aging ProstateNational Cancer Institute2008
  • Mechanisms For Acquired Changes In Prostate Growth RegulationNational Institute Of Diabetes And Digestive And Kidney Diseases2007
  • Modulation Of Genomic Imprinting By Oxidative StressNational Institute Of Diabetes And Digestive And Kidney Diseases2003
  • Genetic Events In Human Prostate Cell TransformationNational Cancer Institute1998–2002

Professional Memberships

Hospital Affiliations